Literature DB >> 19887415

Progress in public-private partnerships to fight neglected diseases.

Kenneth Gustavsen1, Christy Hanson.   

Abstract

In the global fight against neglected tropical diseases (NTDs), public health partnerships involving donations of medicines by pharmaceutical companies are enabling access to treatment for millions of people worldwide. These partnerships collaborate with other disease programs and a range of key stakeholders to develop and improve programs to control and eliminate NTDs. Although progress is being made against NTDs, continued success depends on a policy environment that supports appropriate levels of engagement and collaboration from all participants.

Entities:  

Mesh:

Year:  2009        PMID: 19887415     DOI: 10.1377/hlthaff.28.6.1745

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  10 in total

1.  Global health or global wealth?

Authors:  Rahim Rezaie; Peter A Singer
Journal:  Nat Biotechnol       Date:  2010-09       Impact factor: 54.908

Review 2.  Emerging and reemerging neglected tropical diseases: a review of key characteristics, risk factors, and the policy and innovation environment.

Authors:  Tim K Mackey; Bryan A Liang; Raphael Cuomo; Ryan Hafen; Kimberly C Brouwer; Daniel E Lee
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

3.  Preventive Chemotherapy and Transmission Control (PCT) databank: a tool for planning, implementation and monitoring of integrated preventive chemotherapy for control of neglected tropical diseases.

Authors:  Aya Yajima; Alexei Mikhailov; Pamela S Mbabazi; Albis F Gabrielli; Simona Minchiotti; Antonio Montresor; Dirk Engels
Journal:  Trans R Soc Trop Med Hyg       Date:  2012-02-21       Impact factor: 2.184

4.  Which new approaches to tackling neglected tropical diseases show promise?

Authors:  Jerry M Spiegel; Shafik Dharamsi; Kishor M Wasan; Annalee Yassi; Burton Singer; Peter J Hotez; Christy Hanson; Donald A P Bundy
Journal:  PLoS Med       Date:  2010-05-18       Impact factor: 11.069

5.  Are drug companies living up to their human rights responsibilities? Moving toward assessment.

Authors:  Sofia Gruskin; Zyde Raad
Journal:  PLoS Med       Date:  2010-09-28       Impact factor: 11.069

6.  Product development programs for neglected tropical diseases: A crucial role for expert meetings.

Authors:  Leonie Hussaarts; Kim van der Weijde; Pierre Dome; Elly Kourany-Lefoll; Jutta Reinhard-Rupp; Remco de Vrueh
Journal:  PLoS Negl Trop Dis       Date:  2017-02-23

7.  Medicine donation programmes supporting the global drive to end the burden of neglected tropical diseases.

Authors:  Mark Bradley; Rachel Taylor; Julie Jacobson; Morgane Guex; Adrian Hopkins; Julie Jensen; Lynn Leonard; Johannes Waltz; Luc Kuykens; Papa Salif Sow; Ulrich-Dietmar Madeja; Takayuki Hida; Kileken Ole-Moiyoi; Jonathan King; Daniel Argaw; Jamsheed Mohamed; Maria Rebollo Polo; Aya Yajima; Eric Ottesen
Journal:  Trans R Soc Trop Med Hyg       Date:  2021-01-28       Impact factor: 2.184

8.  Improving access to care in low and middle-income countries: institutional factors related to enrollment and patient outcome in a cancer drug access program.

Authors:  Ebru Tekinturhan; Etienne Audureau; Marie-Pierre Tavolacci; Patricia Garcia-Gonzalez; Joël Ladner; Joseph Saba
Journal:  BMC Health Serv Res       Date:  2013-08-10       Impact factor: 2.655

Review 9.  Challenges in drug discovery targeting TriTryp diseases with an emphasis on leishmaniasis.

Authors:  Laura M Alcântara; Thalita C S Ferreira; Fernanda R Gadelha; Danilo C Miguel
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2018-09-28       Impact factor: 4.077

10.  The NTD Supply Chain Forum-Strengthening the backbone of NTD programs.

Authors:  Ashley A Souza; Cassandra Holloway; Tijana Williams
Journal:  PLoS Negl Trop Dis       Date:  2020-11-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.